Eirini Papapetrou | Mount Sinai

Biography

Research Topics

Cancer Genetics, Hematopoiesis, Stem Cells

Multi-Disciplinary Training Area

Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS], Disease Mechanisms and Therapeutics (DMT)

Eirini Papapetrou studies blood disorders, particularly myeloid malignancies, with human pluripotent stem cells. Her lab developed the first iPSC models of Myelodysplastic Syndromes and Acute Myeloid Leukemia. The Papapetrou lab combines expertise in induced pluripotent stem (iPS) cell generation, genome editing (CRISPR) and hematopoiesis.

Dr. Papapetrou is on Twitter at @PapapetrouMDPhD

Papapetrou Lab

Eirini Papapetrou studies blood disorders, particularly myeloid malignancies, with human pluripotent stem cells. Her lab developed the first iPSC models of Myelodysplastic Syndromes and Acute Myeloid Leukemia. The Papapetrou lab combines expertise in induced pluripotent stem (iPS) cell generation, genome editing (CRISPR) and hematopoiesis.

Dr. Papapetrou is on Twitter at @PapapetrouMDPhD

Research

Research overview:

Visit the Papapetrou Laboratory

Education

MD, University of Patras, Greece

PhD, University of Patras, Greece

Postdoctoral, Memorial Sloan-Kettering Cancer Center

Honors & Awards

2021

American Association for Cancer Research (AACR)-MPM oncology charitable foundation transformative cancer research award

2018

Leukemia & Lymphoma Society (LLS) Scholar Award

2018

Elected member of the American Society for Clinical Investigation (ASCI)

2017

Pershing Square Sohn Prize

2016

Outstanding New Investigator Award

American Society of Gene and Cell Therapy (ASGCT)

2015

Tito Bastianello Young Investigator Award

MDS International Foundation

2014

American Society for Clinical Investigation Young Physician-Scientist Award

American Society for Clinical Investigation (ASCI)

2013

American Society of Hematology (ASH) Junior Faculty Scholar Award

American Society of Hematology (ASH)

2013

Sidney Kimmel Foundation Scholar Award

Sidney Kimmel Foundation for Cancer Research

2013

Aplastic Anemia & MDS IF Research Grant Award

Aplastic Anemia & MDS International Foundation

2013

John H. Tietze Stem Cell Scientist Award

2013

Ellison Medical Foundation New Scholar in Aging Award

Ellison Medical Foundation

2013

Damon Runyon-Rachleff Innovation Award

Damon Runyon Cancer Research Foundation

2013

UW Royalty Research Fund Award

University of Washington

2011

K99/R00 Pathway to Independence Award

NIH/NIDDK

Publications

71

Publications

Selected Publications

Metabolic adaptations to acute glucose uptake inhibition converge upon mitochondrial respiration for leukemia cell survival. Monika Komza, Jesminara Khatun, Jesse D. Gelles, Andrew P. Trotta, Ioana Abraham-Enachescu, Juan Henao, Ahmed Elsaadi, Andriana G. Kotini, Cara Clementelli, Jo Ann Arandela, Sebastian El Ghaity-Beckley, Agneesh Barua, Yiyang Chen, Mirela Berisa, Bridget K. Marcellino, Eirini P. Papapetrou, Masha V. Poyurovsky, Jerry Edward Chipuk. Cell Communication and Signaling

The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development. Christopher M. Sturgeon, Elvin Wagenblast, Franco Izzo, Eirini P. Papapetrou. Blood cancer discovery

Human pluripotent stem cell–derived hematopoietic progenitors and mature cells. Christopher M. Sturgeon, Eirini P. Papapetrou, Shannon McKinney-Freeman. Experimental Hematology

View All Publications

Video

What the AAMDSIF Research Grant meant for this researcher: Eirini Papapetrou, MD, PhD

Cancer Precision Medicine Retreat -- Session 5: Eirini Papapetrou

Office Locations

Hess CSM Building Floor 6 Room 112

1470 Madison Ave

New York, NY 10029

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Papapetrou during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Cellarity

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Papapetrou during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Cellarity

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.